BioSpace News Archive

Global market leader in molded glass packaging solutions for the pharmaceutical industry, SGD Pharma announces the latest expansion of its Sterinity range of Ready-To-Use (RTU) Type I molded glass vials.

Madrigal Pharmaceuticals, Inc. announced that the company granted equity awards to seven new employees with a grant date of October 10, 2023 as equity inducement awards outside of the Company’s Amended 2015 Stock Plan under the terms of the company’s 2023 Inducement Plan.

Rani Therapeutics Holdings, Inc. (“Rani Therapeutics” or “Rani”) (Nasdaq: RANI) today announced that it will present an abstract on RT-102 at the 2023 Annual Meeting of the American Society for Bone and Mineral Research (ASBMR) taking place on October 13-16, 2023 in Vancouver, British Columbia, Canada.

Mindray, a global leader and developer of healthcare solutions and technologies in ultrasound, patient monitoring, and anesthesia, announced a new milestone in their cooperative agreement with Edwards Lifesciences, a global leader in medical innovations for structural heart disease and critical care monitoring.

Edesa Biotech, Inc. announced it has entered into a binding commitment letter in respect of a $10 million revolving credit facility agreement with Dr. Par Nijhawan, MD, the Company’s Chief Executive Officer and Founder.

OpGen, Inc. announced that it has entered into an agreement with an institutional investor that is an existing holder of warrants to purchase common shares of the Company for cash, wherein the investor agreed to exercise the Existing Warrants to purchase up to a maximum of 10,892,728 common shares at an exercise price of $0.7785 per share.

Bracco Imaging S.p.A. received notification that the CHMP of the EMA has adopted a positive opinion recommending approval of Vueway® solution for injection for magnetic resonance imaging for use in adult and pediatric patients aged 2 years and older with magnetic resonance imaging of the CNS and several body organs.

A Plenary Keynote address on the first learnings of the $50 million MOSAIC initiative, whose goal is to revolutionize cancer research through spatial omics technologies

Foley Hoag LLP has now completed the hiring of a new team led by partner Amy Baker Mandragouras, further enhancing the firm’s life sciences and intellectual property offerings.

Zonetail Inc. (TSXV: ZONE) (OTCQB: ZTLLF) (“Zonetail” or the “Company”) is pleased to announce the closing (the “Closing”) of the first tranche of non-brokered private placement of up to $1,000,000 in common shares of the Company at a purchase price of $0.02 per Share (the “Offering”)